We are delighted to extend a special invitation to you to register for the upcoming Biosimilars LatAm -Brazil 2023 in-person Forum, taking place on August 16th and 17th at the hotel Radisson Paulista São Paulo.
The Biosimilars LatAm – Brazil 2023 forum presents the next level discussion for Biosimilars in the country for the interest of producer companies. The interchangeability, as well as new developments and mechanisms supported by ANVISA, will be deeply discussed by authorities, industry leaders and CDMO experts to identify the opportunities that the Brazilian regulatory agency is interested in providing for more biosimilars access to the individuals. The new Latin American regulatory landscape is the central closing conversation with representatives from the biggest markets in the region that will set up the future of opportunities for the industry and patients. A forum that will mark the change for LatAm.
We are pleased to highlight the ANVISA participation in the Opening Ceremony by Meiruze Freitas, Director of the Second Board, as well as Fabricio Carneiro de Oliveira, General Manager presenting “Biosimilar Regulatory Updates” and ANVISA participation in the discussion “New Biosimilar Vision in Brazil, PDP Policy Update and Other Mechanisms for Production.”
Register now by visiting
https://jackleckerman.com/events/register-biosimilars-latam-brazil-2023/?utm_source=roncarati&utm_medium=members&utm_campaign=invitation&utm_term=newsletter2&utm_content=laph122
Visit the official website of the Forum
https://jackleckerman.com/events/biosimilars-latam-brazil-2023?utm_source=roncarati&utm_medium=members&utm_campaign=invitation&utm_term=newsletter2&utm_content=laph122
Join us at the Biosimilars LatAm - Brazil 2023 Forum, and immerse yourself in an exceptional environment of knowledge exchange, networking, and collaborative opportunities. We eagerly look forward to welcoming you and sharing this remarkable experience together.
30.06.2023